Specifically, HER2-CAR-M was found to convert immunosuppressive M2 macrophages into pro-inflammatory M1 macrophages, thereby enhancing the cytotoxic effects of T cells in the tumor microenvironment. Here, ERBB2 is linked to neoplasm.